It was a day for big characters... and big companies.
Billionaire Donald Trump was in focus early on as the Republican candidate won a resounding victory in the New Hampshire Primary
There was also a strong win for leftwing Democrat Bernie Sanders, and the suggestion was that the vote sent a strong signal to the US establishment saying people want a strong shift in policy and personality.
Speaking of wealthy personalities (although now a little less so), Elon Musk, the inventor and entrepreneur was also back in the news.
He has reportedly lost more than US$3 billion, in terms of paper, due to the share fall of the two firms, where he is the largest shareholder - Tesla (NASDAQ:TSLA) and alternative energy company SolarCity (NASDAQ:SCTY). He holds 22% of both.
Shares in the latter crashed 25% today after earnings from the largest residential solar panel installer disappointed and deployments of its technology weakened.
At Tesla, he is the co-founder, chief executive and chairman.
The electric car maker will post latest results after the closing bell on Wednesday, but fears are mounting over production delays for its new Model X SUV.
The fact the crude price is so low doesn't help the cause much either, as it keeps a lid on gasoline prices.
But that doesn't mean Musk is not without potential means.
Tesla was said to be worth about $6.8 billion at the start of the year and is now valued at around $4.4 billion, while despite Solar City's fall Musk's investment is still valued at around US$390 million.
WHAT'S HOT AND WHAT'S NOT...?
RISERS
Amarantus BioScience Holdings (OTCQB: AMBS), up 10% as it reached a key milestone - receiving orphan drug status from the powerful FDA for Eltoprazine for treating the involuntary movements associated with Parkinson's disease, sending shares higher.
World Moto (OTCMKTSL:FARE), up over 18%. Yesterday, the group inked a new distribution deal which will see its Moto-Meter product throughout Kenya.
Edge Therapeutics (NASDAQ:EDGE), up over 13% as it announced the full set of results from its North American Phase I/II study of its EG-1962 treatment for NEWTON will be presented at the International Stroke Conference 2016.
FALLERS
Disney (NYSE:DIS) down 3.5% despite reporting the "highest quarterly earnings" in its history driven by the success of the latest Star Wars offering. Investors were disappointed about the cable network side of the business.
Orion Energy Systems (NASDAQ:OESX) , down almost 32% after quarterly earnings. The company reported EPS, which missed the Thomson Reuters’ consensus estimate.
SolarCity (NASDAQ:SCTY) , down 25% as the firm chaired by Elon Musk, reported a bigger-than-expected loss for the first quarter as installations fall short of its target.